Literature DB >> 8393684

Malignant phyllodes tumours of the breast. A clinical and pathological analysis of 55 cases.

M Reinfuss1, J Mituś, K Smolak, A Stelmach.   

Abstract

55 cases of malignant phyllodes tumours of the breast are described. 36 patients (i.e. 65.5%) of the studied group survived 5 years with no evidence of disease after surgery. It was proved that a simple mastectomy is sufficient therapy for patients with tumour limited to the breast. Metastases to the axillary lymphatic nodes are very rare. The main reason for treatment failure is distant metastases in the lungs. The only prognostic factor in the studied group was the grade of histological malignancy, determined by such criteria as the ratio between the malignant sarcomatous tissue and that typical for phyllodes tumour, the degree of cell polymorphism, mitotic activity, and possible multidirectional differentiation (towards malignant neoplasms of soft tissue and bones).

Entities:  

Mesh:

Year:  1993        PMID: 8393684     DOI: 10.1016/0959-8049(93)90067-p

Source DB:  PubMed          Journal:  Eur J Cancer        ISSN: 0959-8049            Impact factor:   9.162


  14 in total

1.  Phyllodes Tumor of the Breast: Pathology, Histogenesis, Diagnosis, and Treatment.

Authors: 
Journal:  Breast Cancer       Date:  1996-06-28       Impact factor: 4.239

2.  Effects of adjuvant radiotherapy on borderline and malignant phyllodes tumors: A systematic review and meta-analysis.

Authors:  Shiyan Zeng; Xindan Zhang; Dejuan Yang; Xiaoyi Wang; Guosheng Ren
Journal:  Mol Clin Oncol       Date:  2015-02-06

3.  Palliative treatment of metastatic phyllodes tumors: a case series.

Authors:  Vithusha Ganesh; Justin Lee; Bo Angela Wan; Eileen Rakovitch; Danny Vesprini; Elzbieta Slodkowska; K Liang Zeng; Philomena Sousa; Caitlin Yee; Edward Chow
Journal:  AME Case Rep       Date:  2017-12-21

4.  Adrenal metastasis of a phyllodes tumor of the breast: Case report and review of the literature.

Authors:  Yves Collin; François Chagnon; Charles J Mongeau; Gonzalo L Gonzalez-Amaya; Lucas Sideris
Journal:  Int J Surg Case Rep       Date:  2013-05-14

Review 5.  Phyllodes tumours.

Authors:  S J Parker; S A Harries
Journal:  Postgrad Med J       Date:  2001-07       Impact factor: 2.401

6.  Endothelin-1 expression correlates with atypical histological features in mammary phyllodes tumours.

Authors:  Gary M Tse; Benjaporn Chaiwun; Kin-Mang Lau; Richard Scolyer; C Soon Lee; Rooshdiya Z Karim; Thomas C Putti; Bonita K Law; Philip C Lui; Puay Hoon Tan
Journal:  J Clin Pathol       Date:  2006-12-08       Impact factor: 3.411

7.  A prospective, multi-institutional study of adjuvant radiotherapy after resection of malignant phyllodes tumors.

Authors:  Richard J Barth; Wendy A Wells; Sandra E Mitchell; Bernard F Cole
Journal:  Ann Surg Oncol       Date:  2009-05-08       Impact factor: 5.344

8.  Changes in the clinical characteristics, treatment options, and therapy outcomes in patients with phyllodes tumor of the breast during 55 years of experience.

Authors:  Jerzy Władysław Mituś; Paweł Blecharz; Marian Reinfuss; Jan Kanty Kulpa; Piotr Skotnicki; Wojciech Maria Wysocki
Journal:  Med Sci Monit       Date:  2013-12-19

Review 9.  Phyllodes tumors of the breast.

Authors:  S A Khan; S Badve
Journal:  Curr Treat Options Oncol       Date:  2001-04

10.  Comprehensive characterization of malignant phyllodes tumor by whole genomic and proteomic analysis: biological implications for targeted therapy opportunities.

Authors:  Denis L Fontes Jardim; Anthony Conley; Vivek Subbiah
Journal:  Orphanet J Rare Dis       Date:  2013-07-30       Impact factor: 4.123

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.